Drugs / tetanus, diphtheria toxoid, adsorbed
tetanus, diphtheria toxoid, adsorbed
Trials 0
Also used as a comparator or background therapy in 1 trial
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT03299309 Background | Jun 2018 → Apr 2023 overdue | brain cancer, malignant glioma, medulloblastoma | Daniel Landi | Active not recruiting | No outcome recorded |
Evidence & citations 4 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | tetanus, diphtheria toxoid, adsorbed | “On day 20, patients will receive a Tetanus-diphtheria pre-conditioning vaccination with Td (tetanus, diphtheria toxoid, adsorbed).” NCT03299309 ↗ |
| Known as | Td | ClinicalTrials.gov intervention name — accepted as the source's own label NCT03299309 ↗ |
| Known as | Tetanus-diphtheria | “On day 20, patients will receive a Tetanus-diphtheria pre-conditioning vaccination with Td (tetanus, diphtheria toxoid, adsorbed).” NCT03299309 ↗ |
| Modality | Vaccine | “Tetanus-diphtheria pre-conditioning vaccination” NCT03299309 ↗ |